Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis
Publication type: Journal Article
Publication date: 2023-12-06
scimago Q2
wos Q3
SJR: 0.624
CiteScore: 5.5
Impact factor: 2.4
ISSN: 08820139, 15324311
PubMed ID:
38054436
General Medicine
Immunology
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
JOR Spine
1 publication, 25%
|
|
|
Molecular Medicine Reports
1 publication, 25%
|
|
|
Frontiers in Neurology
1 publication, 25%
|
|
|
Life
1 publication, 25%
|
|
|
1
|
Publishers
|
1
|
|
|
Wiley
1 publication, 25%
|
|
|
Spandidos Publications
1 publication, 25%
|
|
|
Frontiers Media S.A.
1 publication, 25%
|
|
|
MDPI
1 publication, 25%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
4
Total citations:
4
Citations from 2024:
4
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Srikanth M., Rasool M. Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis // Immunological Investigations. 2023. Vol. 53. No. 2. pp. 1-45.
GOST all authors (up to 50)
Copy
Srikanth M., Rasool M. Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis // Immunological Investigations. 2023. Vol. 53. No. 2. pp. 1-45.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/08820139.2023.2288836
UR - https://doi.org/10.1080/08820139.2023.2288836
TI - Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis
T2 - Immunological Investigations
AU - Srikanth, Manupati
AU - Rasool, Mahaboobkhan
PY - 2023
DA - 2023/12/06
PB - Taylor & Francis
SP - 1-45
IS - 2
VL - 53
PMID - 38054436
SN - 0882-0139
SN - 1532-4311
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Srikanth,
author = {Manupati Srikanth and Mahaboobkhan Rasool},
title = {Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis},
journal = {Immunological Investigations},
year = {2023},
volume = {53},
publisher = {Taylor & Francis},
month = {dec},
url = {https://doi.org/10.1080/08820139.2023.2288836},
number = {2},
pages = {1--45},
doi = {10.1080/08820139.2023.2288836}
}
Cite this
MLA
Copy
Srikanth, Manupati, and Mahaboobkhan Rasool. “Resistin – A Plausible Therapeutic Target in the Pathogenesis of Psoriasis.” Immunological Investigations, vol. 53, no. 2, Dec. 2023, pp. 1-45. https://doi.org/10.1080/08820139.2023.2288836.